Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α

被引：0
|
作者：
Tromm, A
Greving, I
Hueppe, D
机构：
[1] BG Clinen BERGMANNSHEIL, Bochum, Germany
[2] Ruhr Univ Bochum, D-4630 Bochum, Germany
[3] Gastroemterp Fachpraxis, Herne, Germany
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G3621
引用
收藏
页码：A834 / A834
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C
    Iwona Mozer-Lisewska
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 316 - 317
  • [42] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [43] Soreness of mucosal membranes in patients receiving interferon-α plus ribavirin for treatment of chronic hepatitis C.
    Stauber, RE
    Trauner, M
    Fickert, P
    HEPATOLOGY, 1998, 28 (04) : 704A - 704A
  • [44] Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C - A randomised, controlled pilot study
    Wenger, Christa
    Bischof, Thomas
    Gonvers, Jean-Jacques
    Renner, Eberhard L.
    Mullhaupt, Beat
    SWISS MEDICAL WEEKLY, 2007, 137 (29-30) : 418 - 423
  • [45] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [46] Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders
    Kao, JH
    Lai, MY
    Chen, PJ
    Cheng, YM
    Chen, DS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (10) : 662 - 667
  • [47] Interferon-α and ribavirin treatment of hepatitis C in children with malignancy in remission
    Christensson, B
    Wiebe, T
    Åkesson, A
    Widell, A
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) : 585 - 586
  • [48] Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-α therapy
    Böcher, WO
    Schuchmann, M
    Link, R
    Hillenbrand, H
    Rahman, F
    Sprinzl, M
    Mudter, J
    Löhr, HF
    Galle, PR
    LIVER INTERNATIONAL, 2006, 26 (03) : 319 - 325
  • [49] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [50] Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-α combination therapy and interferon-α monotherapy of patients with chronic hepatitis C
    Hoffmann, RM
    Berg, T
    Teuber, G
    Prümmer, O
    Leifeld, L
    Jung, MC
    Spengler, U
    Zeuzem, S
    Hopf, U
    Pape, GR
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1999, 37 (08): : 715 - 723
12345